1-3 of 3
Shruthi Naik
Close
Sort by
Journal Articles

Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients with Relapsed or Refractory Multiple Myeloma (MM), Acute Myeloid Leukemia (AML), and T-Cell Neoplasms (TCL)

Martha Q. Lacy, MD, Kah-Whye Peng, PhD, Stephen J. Russell, MD PhD, Amylou C. Dueck, PhD, Mrinal M. Patnaik, MD MBBS, Thomas E. Witzig, MD, Brenda F Ginos, Francis K. Buadi, MB, CHB, Angela Dispenzieri, MD, Morie A. Gertz, MD, Ronald S. Go, MD, Suzanne R. Hayman, MD, John A. Lust, MD PhD, David Dingli, MD PhD, S. Vincent Rajkumar, MD, Nelson Leung, MD, Rahma Warsame, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, Eli Muchtar, MD, Stephen Broski, MD, Robert C Murphy, MD PhD, Prashant Kapoor, MD, Robert A. Kyle, MD, Steven Zeldenrust, MD, Aref Al-Kali, MD, Mark R. Litzow, MD, Shruthi Naik, PhD, Mark J Federspiel, PhD, Shaji K. Kumar, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3268.
https://doi.org/10.1182/blood-2018-99-119444
Published: 2018
Journal Articles

Engineering VSV-IFN-NIS for the Treatment of Multiple Myeloma.

Shruthi Naik, Rebecca A. Nace, Elizabeth A. Hadac, David Dingli, M.D., PhD., Mark Federspiel, Glen N. Barber, Stephen J. Russell, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 378.
https://doi.org/10.1182/blood.V114.22.378.378
Published: 2009
Journal Articles

Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Δ51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene

Apollina Goel, Stephanie K. Carlson, Kelly L. Classic, Suzanne Greiner, Shruthi Naik, Anthony T. Power, John C. Bell, Stephen J. Russell
Journal: Blood
Blood (2007) 110 (7): 2342–2350.
https://doi.org/10.1182/blood-2007-01-065573
Published: 2007